Cargando…
Fish Oil Enriched Intravenous Lipid Emulsions Reduce Triglyceride Levels in Non-Critically Ill Patients with TPN and Type 2 Diabetes. A Post-Hoc Analysis of the INSUPAR Study
There are no studies that have specifically assessed the role of intravenous lipid emulsions (ILE) enriched with fish oil in people with diabetes receiving total parenteral nutrition (TPN). The objective of this study was to assess the metabolic control (glycemic and lipid) and in-hospital complicat...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352525/ https://www.ncbi.nlm.nih.gov/pubmed/32471262 http://dx.doi.org/10.3390/nu12061566 |
_version_ | 1783557658368802816 |
---|---|
author | Abuín-Fernández, Jose Tapia-Guerrero, María José López-Urdiales, Rafael Herranz-Antolín, Sandra García-Almeida, Jose Manuel García-Malpartida, Katherine Ferrer-Gómez, Mercedes Cancer-Minchot, Emilia Luengo-Pérez, Luis Miguel Álvarez-Hernández, Julia Aragón Valera, Carmen Ocón-Bretón, Julia García-Manzanares, Álvaro Bretón-Lesmes, Irene Serrano-Aguayo, Pilar Pérez-Ferre, Natalia López-Gómez, Juan José Olivares-Alcolea, Josefina Arraiza-Irigoyen, Carmen Tejera-Pérez, Cristina Martínez-González, Jorge Daniel Urioste-Fondo, Ana Abad-González, Ángel Luis Molina-Puerta, María José Zugasti-Murillo, Ana Parra-Barona, Juan López-Cobo, Irela Olveira, Gabriel |
author_facet | Abuín-Fernández, Jose Tapia-Guerrero, María José López-Urdiales, Rafael Herranz-Antolín, Sandra García-Almeida, Jose Manuel García-Malpartida, Katherine Ferrer-Gómez, Mercedes Cancer-Minchot, Emilia Luengo-Pérez, Luis Miguel Álvarez-Hernández, Julia Aragón Valera, Carmen Ocón-Bretón, Julia García-Manzanares, Álvaro Bretón-Lesmes, Irene Serrano-Aguayo, Pilar Pérez-Ferre, Natalia López-Gómez, Juan José Olivares-Alcolea, Josefina Arraiza-Irigoyen, Carmen Tejera-Pérez, Cristina Martínez-González, Jorge Daniel Urioste-Fondo, Ana Abad-González, Ángel Luis Molina-Puerta, María José Zugasti-Murillo, Ana Parra-Barona, Juan López-Cobo, Irela Olveira, Gabriel |
author_sort | Abuín-Fernández, Jose |
collection | PubMed |
description | There are no studies that have specifically assessed the role of intravenous lipid emulsions (ILE) enriched with fish oil in people with diabetes receiving total parenteral nutrition (TPN). The objective of this study was to assess the metabolic control (glycemic and lipid) and in-hospital complications that occurred in non-critically ill inpatients with TPN and type 2 diabetes with regard to the use of fish oil emulsions compared with other ILEs. We performed a post-hoc analysis of the Insulin in Parenteral Nutrition (INSUPAR) trial that included patients who started with TPN for any cause and that would predictably continue with TPN for at least five days. The study included 161 patients who started with TPN for any cause. There were 80 patients (49.7%) on fish oil enriched ILEs and 81 patients (50.3%) on other ILEs. We found significant decreases in triglyceride levels in the fish oil group compared to the other patients. We did not find any differences in glucose metabolic control: mean capillary glucose, glycemic variability, and insulin dose, except in the number of mild hypoglycemic events that was significantly higher in the fish oil group. We did not observe any differences in other metabolic, liver or infectious complications, in-hospital length of stay or mortality. |
format | Online Article Text |
id | pubmed-7352525 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73525252020-07-15 Fish Oil Enriched Intravenous Lipid Emulsions Reduce Triglyceride Levels in Non-Critically Ill Patients with TPN and Type 2 Diabetes. A Post-Hoc Analysis of the INSUPAR Study Abuín-Fernández, Jose Tapia-Guerrero, María José López-Urdiales, Rafael Herranz-Antolín, Sandra García-Almeida, Jose Manuel García-Malpartida, Katherine Ferrer-Gómez, Mercedes Cancer-Minchot, Emilia Luengo-Pérez, Luis Miguel Álvarez-Hernández, Julia Aragón Valera, Carmen Ocón-Bretón, Julia García-Manzanares, Álvaro Bretón-Lesmes, Irene Serrano-Aguayo, Pilar Pérez-Ferre, Natalia López-Gómez, Juan José Olivares-Alcolea, Josefina Arraiza-Irigoyen, Carmen Tejera-Pérez, Cristina Martínez-González, Jorge Daniel Urioste-Fondo, Ana Abad-González, Ángel Luis Molina-Puerta, María José Zugasti-Murillo, Ana Parra-Barona, Juan López-Cobo, Irela Olveira, Gabriel Nutrients Article There are no studies that have specifically assessed the role of intravenous lipid emulsions (ILE) enriched with fish oil in people with diabetes receiving total parenteral nutrition (TPN). The objective of this study was to assess the metabolic control (glycemic and lipid) and in-hospital complications that occurred in non-critically ill inpatients with TPN and type 2 diabetes with regard to the use of fish oil emulsions compared with other ILEs. We performed a post-hoc analysis of the Insulin in Parenteral Nutrition (INSUPAR) trial that included patients who started with TPN for any cause and that would predictably continue with TPN for at least five days. The study included 161 patients who started with TPN for any cause. There were 80 patients (49.7%) on fish oil enriched ILEs and 81 patients (50.3%) on other ILEs. We found significant decreases in triglyceride levels in the fish oil group compared to the other patients. We did not find any differences in glucose metabolic control: mean capillary glucose, glycemic variability, and insulin dose, except in the number of mild hypoglycemic events that was significantly higher in the fish oil group. We did not observe any differences in other metabolic, liver or infectious complications, in-hospital length of stay or mortality. MDPI 2020-05-27 /pmc/articles/PMC7352525/ /pubmed/32471262 http://dx.doi.org/10.3390/nu12061566 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Abuín-Fernández, Jose Tapia-Guerrero, María José López-Urdiales, Rafael Herranz-Antolín, Sandra García-Almeida, Jose Manuel García-Malpartida, Katherine Ferrer-Gómez, Mercedes Cancer-Minchot, Emilia Luengo-Pérez, Luis Miguel Álvarez-Hernández, Julia Aragón Valera, Carmen Ocón-Bretón, Julia García-Manzanares, Álvaro Bretón-Lesmes, Irene Serrano-Aguayo, Pilar Pérez-Ferre, Natalia López-Gómez, Juan José Olivares-Alcolea, Josefina Arraiza-Irigoyen, Carmen Tejera-Pérez, Cristina Martínez-González, Jorge Daniel Urioste-Fondo, Ana Abad-González, Ángel Luis Molina-Puerta, María José Zugasti-Murillo, Ana Parra-Barona, Juan López-Cobo, Irela Olveira, Gabriel Fish Oil Enriched Intravenous Lipid Emulsions Reduce Triglyceride Levels in Non-Critically Ill Patients with TPN and Type 2 Diabetes. A Post-Hoc Analysis of the INSUPAR Study |
title | Fish Oil Enriched Intravenous Lipid Emulsions Reduce Triglyceride Levels in Non-Critically Ill Patients with TPN and Type 2 Diabetes. A Post-Hoc Analysis of the INSUPAR Study |
title_full | Fish Oil Enriched Intravenous Lipid Emulsions Reduce Triglyceride Levels in Non-Critically Ill Patients with TPN and Type 2 Diabetes. A Post-Hoc Analysis of the INSUPAR Study |
title_fullStr | Fish Oil Enriched Intravenous Lipid Emulsions Reduce Triglyceride Levels in Non-Critically Ill Patients with TPN and Type 2 Diabetes. A Post-Hoc Analysis of the INSUPAR Study |
title_full_unstemmed | Fish Oil Enriched Intravenous Lipid Emulsions Reduce Triglyceride Levels in Non-Critically Ill Patients with TPN and Type 2 Diabetes. A Post-Hoc Analysis of the INSUPAR Study |
title_short | Fish Oil Enriched Intravenous Lipid Emulsions Reduce Triglyceride Levels in Non-Critically Ill Patients with TPN and Type 2 Diabetes. A Post-Hoc Analysis of the INSUPAR Study |
title_sort | fish oil enriched intravenous lipid emulsions reduce triglyceride levels in non-critically ill patients with tpn and type 2 diabetes. a post-hoc analysis of the insupar study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352525/ https://www.ncbi.nlm.nih.gov/pubmed/32471262 http://dx.doi.org/10.3390/nu12061566 |
work_keys_str_mv | AT abuinfernandezjose fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT tapiaguerreromariajose fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT lopezurdialesrafael fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT herranzantolinsandra fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT garciaalmeidajosemanuel fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT garciamalpartidakatherine fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT ferrergomezmercedes fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT cancerminchotemilia fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT luengoperezluismiguel fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT alvarezhernandezjulia fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT aragonvaleracarmen fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT oconbretonjulia fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT garciamanzanaresalvaro fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT bretonlesmesirene fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT serranoaguayopilar fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT perezferrenatalia fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT lopezgomezjuanjose fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT olivaresalcoleajosefina fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT arraizairigoyencarmen fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT tejeraperezcristina fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT martinezgonzalezjorgedaniel fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT uriostefondoana fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT abadgonzalezangelluis fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT molinapuertamariajose fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT zugastimurilloana fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT parrabaronajuan fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT lopezcoboirela fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy AT olveiragabriel fishoilenrichedintravenouslipidemulsionsreducetriglyceridelevelsinnoncriticallyillpatientswithtpnandtype2diabetesaposthocanalysisoftheinsuparstudy |